Matakina Technology in Move to Larger Offices   18 Sep 2014

Matakina Technology in Move to Larger Offices

WELLINGTON, 18 September 2014 – Breast screening software developer Matakina Technology officially opened their new Wellington offices on Tuesday.

British High Commissioner to New Zealand, Jonathan Sinclair, cut the opening ribbon saying, “Since I arrived in Wellington, I have been struck by the depth, strength and diversity of links between New Zealand and the UK, both bilaterally and in partnership in other countries. Matakina is emblematic of those ties: a truly global company - seeded in the UK, based in New Zealand and now servicing the world.”

Serial medtech entrepreneur Professor Sir Michael Brady from Oxford University is a founder in Matakina and is visiting New Zealand as a speaker at MORGO in Waitangi. Presenting at the opening he said, “Breast screening using mammography is proven to save lives, however, it is not perfect, especially for women with extremely dense breasts.

“The breast density story is leading to a global revolution in breast screening that is saving lives and reducing costs. Volpara is ensuring cancers are detected early, thus reducing treatment costs, whilst also ensuring that only women that need additional imaging actually receive it.”

Matakina’s flagship product VolparaDensity is used by radiologists to objectively assess density from both digital mammography and tomosynthesis (3D mammography) images to help doctors evaluate who might benefit from additional screening. In the US, 19 states have breast density notification laws, and a federal bill to notify all women of their mammographic density is in congress.

Matakina is currently seeking $5 million capital in an investment round to expand sales and marketing.

The company says that national screening trials are underway in the Netherlands, Norway, Ireland, UK, Germany and Belgium, and will be able to announce several more soon.

About Matakina

Founded to enable radiologists to give women the most accurate information possible regarding their breast health, Volpara Solutions Limited is the wholly owned sales and marketing arm of Matakina Technology Limited of New Zealand. Volpara’s founders and Board of Directors includes John Hood, PhD, former Vice Chancellor of the University of Oxford, UK; Ralph Highnam, PhD, former CEO of Mirada Solutions, one of the University of Oxford’s most successful spin-outs of recent times and co-author of the seminal book Mammographic Image Analysis; and Professor Sir Michael Brady, a serial entrepreneur who recently retired from the University of Oxford where he was Professor of Information Technology for 25 years.

Add a comment